公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
BenchMark Special Stain AFB Staining Kit10287411456ROCHE DIAGNÓSTICA BRASIL LTDAI现有
BenchMark Special Stains Wash II10287411442ROCHE DIAGNÓSTICA BRASIL LTDAI现有
BenchMark ULTRA PLUS10287411640ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Benzodiazepines II10287410973ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Bilirubin total Gen.310287411018ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.F.A.S. - CALIBRATOR FOR AUTOMATED SYSTEMS10287410378ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.F.A.S. LIPIDS10287410515ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.F.A.S. PAC10287410437ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.F.A.S. PUC10287410389ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.f.a.s DAT Qualitative Plus10287410712ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.f.a.s HbA1c10287410703ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.f.a.s. Cystatin C10287411050ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.f.a.s. IgA/IgM CSF10287411068ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C.f.a.s. Myoglobin10287410713ROCHE DIAGNÓSTICA BRASIL LTDAIII17/11/2035
C3C-2 (Tina-quant Complement C3c ver.2)_cobas c10287411468ROCHE DIAGNÓSTICA BRASIL LTDAII现有
C4-2 (Tina-quant Complement C4 ver.2)_cobas c10287411470ROCHE DIAGNÓSTICA BRASIL LTDAII现有
CA125 II CalSet II10287411081ROCHE DIAGNÓSTICA BRASIL LTDAIII02/02/2035
CA2 (Calcium Gen.2)_cobas c10287411408ROCHE DIAGNÓSTICA BRASIL LTDAII现有
CALIBRADOR HB10287410442ROCHE DIAGNÓSTICA BRASIL LTDAII现有
CANNABINOIDS II10287410690ROCHE DIAGNÓSTICA BRASIL LTDAII现有
CARB 4 - ONLINE TDM CARBAMAZEPINE GEN.410287411197ROCHE DIAGNÓSTICA BRASIL LTDAIII19/05/2035
CARB4 (ONLINE TDM Carbamazepine Gen.4)_cobas c10287411418ROCHE DIAGNÓSTICA BRASIL LTDAIII10/02/2035
CARDIAC D DIMERO10287410066ROCHE DIAGNÓSTICA BRASIL LTDAIII02/07/2033
CARDIAC D DIMERO CONTROLE10287410080ROCHE DIAGNÓSTICA BRASIL LTDAIII02/07/2033
CC 25 mM (Calcium Chloride 25 mM)10287411178ROCHE DIAGNÓSTICA BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家